Expression and hypoxia-responsiveness of 6-phosphofructo-2-kinase/fructose- 2,6-bisphosphatase 4 in mammary gland malignant cell lines

Acta Biochimica Polonica

Volumn 52, Issue 4, 2005, Pages 881-888

  Minchenko, Oleksandr H ^a,d   Opentanova, Iryna L ^a   Ogura, Tsutomu ^b   Minchenko, Dmytro O ^a   Komisarenko, Sergiy V ^a   Caro, Jaime ^c   Esumi, Hiroyasu ^b  

^a PALLADIN INSTITUTE OF BIOCHEMISTRY   (Ukraine)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d Foundation for Promotion of Cancer Research   (Japan)

Author keywords

Dimethyloxalylglycine; HIF 1; Hypoxia; Mammary gland cancer cell lines; PFKFB4

Indexed keywords

EID: 31544463794     PISSN: 0001527X     EISSN: 1734154X     Source Type: Journal    
DOI: 10.18388/abp.2005_3402     Document Type: Article

References (37)

1. Armstead VE, Opentanova IL, Minchenko AG, Lefer AM (1999) Tissue factor gene expression in vital organs during murine traumatic shock: role of transcription factors AP-1 and NF-κB. Anesthesiology 91: 1844-1852.
2. Atsumi T, Chesney J, Metz C, Leng L, Donnelly S, Makita Z, Mitchell R, Bucala R (2002) High expression of inducible 6-phosphofructo-2-kinase/fructose- 2,6-bisphosphatase-3 (iPFK-2; PFKFB3) in human cancers. Cancer Res 62: 5881-5887.
3. Brown JM, Giaccia AM (1998) The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 58: 1408-1416.
4. Chesney J, Mitchell R, Benigni F, Bacher M, Spiegel L, Al-Abed Y, Han JH, Metz C, Bucala R (1999) An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: role in tumor cell glycolysis and the Warburg effect. Proc Natl Acad Sci USA 96: 3047-3052.
5. Crepin KM, Darville MI, Hue L, Rousseau GG (1989) Characterization of distinct mRNAs coding for putative isozymes of 6-phosphofructo-2-kinase/ fructose-2,6-bisphosphatase. Eur J Biochem 183: 433-440.
6. Dang CV, Semenza GL (1999) Oncogenic alterations of metabolism. Trends Biochem Sci 24: 68-76.
7. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R, Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ, Ratcliffe PJ (2001) C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107: 43-54.
8. Gleade JM, Ratcliffe PJ (1998) Hypoxia and the regulation of gene expression. Mol Med Today 4: 122-129.
9. Gleadle JM, Ebert BL, Firth JD, Ratcliffe PJ (1995) Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents. Am J Physiol 268: C1362-C1368.
10. Hockel M, Vaupel P (2001) Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93: 266-276.
11. Hopfl G, Ogunshola O, Gassmann M (2004) HIFs and tumors - causes and consequences. Am J Physiol 286: R608-R623.
12. Hue L, Beauloye C, Bertrand L, Horman S, Krause U, Marsin A-S, Meisse D, Vertommen D, Rider MH (2003) New targets of AMP-activated protein kinase. Biochem Soc Trans 31: 213-215.
13. 2 sensing. Science 292: 464-468.
14. Lando D, Peet DJ, Whelan DA, Gorman JJ, Whitelaw ML (2002) Asparagine hydroxylation of the HIF transactivation domain: a hypoxic switch. Science 295: 858-861.
15. Lu H, Forbes RA, Verma A (2002) Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J Biol Chem 277: 23111-23115.
16. Manzano A, Rosa JL, Ventura F, Perez JX, Nadal M, Estivill X, Ambrosio S, Gil J, Bartrons R (1998) Cloning, expression and chromosomal localization of a human testis 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene. Gene 229: 83-89.
17. Marsin AS, Douzin C, Bertrand L, Hue L (2002) The stimulation of glycolysis by hypoxia in activated monocytes is mediated by AMP-activated protein kinase and inducible 6-phosphofructo-2-kinase. J Biol Chem 277: 30778-30783.
18. 2 levels. J Cell Sci 116: 3041-3049.
19. Metzen E, Ratcliffe PJ (2004) HIF hydroxylation and cellular oxygen sensing. Biol Chem 385: 223-230.
20. Min J-H, Yang H, Ivan M, Gertler F, Kaelin WGJ Jr, Pavletich NP (2002) Structure of an HIF-1α-pVHL complex: hydroxyproline recognition in signaling. Science 296: 1886-1889.
21. Minchenko A, Caro J (2000) Regulation of endothelin-1 gene expression in human microvascular endothelial cells by hypoxia and cobalt: role of hypoxia responsive element. Mol Cell Biochem 208: 53-62.
22. Minchenko A, Bauer T, Salceda S, Caro J (1994) Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab Invest 71: 374-379.
23. Minchenko A, Leshchinsky I, Opentanova I, Sang N, Srinivas V, Armstead V, Caro J (2002) Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene: its possible role in the Warburg effect. J Biol Chem 277: 6183-6187.
24. Minchenko O, Opentanova I, Caro J (2003) Hypoxic regulation of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene family (PFKFB-1-4) expression in vivo. FEBS Lett 554: 264-270.
25. Minchenko OH, Opentanova IL, Minchenko DO, Ogura T, Esumi H (2004) Hypoxia induces transcription of 6-phosphofructo-2-kinase/fructose-2,6- bisphosphatase 4 gene via hypoxia inducible factor-1alpha activation. FEBS Lett 576: 14-20.
26. Mole DR, Schlemminger I, McNeil LA, Hewitson KS, Pugh CW, Ratcliffe PJ, Schofield CJ (2003) 2-Oxoglutarate analogue inhibitors of HIF prolyl hydroxylase. Bioorg Med Chem Lett 13, 2677-2680.
27. Mueller MD, Vigne J-L, Minchenko A, Lebovic DI, Leitman DC, Taylor RN (2000) Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors α and β. Proc Natl Acad Sci USA 97: 10972-10977.
28. Okar DA, Manzano A, Navarro-Sabate A, Riera L, Bartrons R, Lange A (2001) PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate. Trends Biochem Sci 26: 30-35.
29. Pilkis SJ, Claus TH, Kurland IJ, Lange AJ (1995) 6-Phosphofructo-2- kinase/fructose-2,6-bisphosphatase: a metabolic signaling enzyme. Annu Rev Biochem 64: 799-835.
30. Rider MH, Bertrand L, Vertommen D, Michels PA, Rousseau GG, Hue L (2004) 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase: head-head with a bifunctional enzyme that controls glycolysis. Biochem J 381: 561-578.
31. Sakakibara R, Okudaira T, Fujiwara K, Kato M, Hirata T, Yamanaka S, Naito M, Fukasawa M (1999) Tissue distribution of placenta-type 6-phosphofructo-2- kinase/fructose-2,6-bisphosphatase. Biochem Biophys Res Commun 257: 177-181.
32. Sakata J, Abe Y, Uyeda K (1991) Molecular cloning of the DNA and expression and characterization of rat testes fructose-6-phosphate,2-kinase: fructose-2,6-bisphosphatase. J Biol Chem 266: 15764-15770.
33. Schofield CJ, Ratcliffe PJ (2004) Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 5: 343-354.
34. Vaupel P (1996) Oxygen transport in tumors: characteristics and clinical implications. Adv Exp Med Biol 388: 341-351.
35. Warburg O, Wind F, Negalein E (1927) The metabolism of tumours in the body. J Physiol 8: 519-530.
36. Warburg O (1956) On respiratory impairment in cancer cells. Science 123: 309-314.
37. 2-regulated gene expression. FASEB J 16: 1151-1162.